222 related articles for article (PubMed ID: 23073692)
1. No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan.
Nakajima A; Saito K; Kojima T; Amano K; Yoshio T; Fukuda W; Inoue E; Taniguchi A; Momohara S; Minota S; Takeuchi T; Ishiguro N; Tanaka Y; Yamanaka H
Mod Rheumatol; 2013 Sep; 23(5):945-52. PubMed ID: 23073692
[TBL] [Abstract][Full Text] [Related]
2. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.
Nakajima A; Inoue E; Tanaka E; Singh G; Sato E; Hoshi D; Shidara K; Hara M; Momohara S; Taniguchi A; Kamatani N; Yamanaka H
Scand J Rheumatol; 2010; 39(5):360-7. PubMed ID: 20476859
[TBL] [Abstract][Full Text] [Related]
3. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Rutherford AI; Subesinghe S; Hyrich KL; Galloway JB
Ann Rheum Dis; 2018 Jun; 77(6):905-910. PubMed ID: 29592917
[TBL] [Abstract][Full Text] [Related]
4. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Harigai M; Nanki T; Koike R; Tanaka M; Watanabe-Imai K; Komano Y; Sakai R; Yamazaki H; Koike T; Miyasaka N
Mod Rheumatol; 2016 Sep; 26(5):642-50. PubMed ID: 26873430
[TBL] [Abstract][Full Text] [Related]
5. Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population-based cohort study in Taiwan.
Tang CH; Yu F; Huang CY; Chen DY
Int J Rheum Dis; 2019 Aug; 22(8):1544-1552. PubMed ID: 31240863
[TBL] [Abstract][Full Text] [Related]
6. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J;
Ann Rheum Dis; 2015 Jun; 74(6):1212-7. PubMed ID: 24608401
[TBL] [Abstract][Full Text] [Related]
7. Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
Raaschou P; Simard JF; Neovius M; Askling J;
Arthritis Rheum; 2011 Jul; 63(7):1812-22. PubMed ID: 21305513
[TBL] [Abstract][Full Text] [Related]
8. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
Simard JF; Neovius M; Askling J;
Arthritis Rheum; 2012 Nov; 64(11):3502-10. PubMed ID: 22886739
[TBL] [Abstract][Full Text] [Related]
10. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
Kamata Y; Minota S
Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
[TBL] [Abstract][Full Text] [Related]
11. The British Society for Rheumatology Biologics Register: 6 years on.
Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
[No Abstract] [Full Text] [Related]
12. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.
Björnådal L; Baecklund E; Yin L; Granath F; Klareskog L; Ekbom A
J Rheumatol; 2002 May; 29(5):906-12. PubMed ID: 12022348
[TBL] [Abstract][Full Text] [Related]
13. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
Gerhold K; Richter A; Schneider M; Bergerhausen HJ; Demary W; Liebhaber A; Listing J; Zink A; Strangfeld A
Rheumatology (Oxford); 2015 Oct; 54(10):1858-66. PubMed ID: 26001633
[TBL] [Abstract][Full Text] [Related]
15. How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study.
Lassere MN; Rappo J; Portek IJ; Sturgess A; Edmonds JP
Intern Med J; 2013 Jan; 43(1):66-72. PubMed ID: 22289054
[TBL] [Abstract][Full Text] [Related]
16. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
17. Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.
George MD; Baker JF; Winthrop K; Alemao E; Chen L; Connolly S; Hsu JY; Simon TA; Wu Q; Xie F; Yang S; Curtis JR
Ann Intern Med; 2019 Jun; 170(12):825-836. PubMed ID: 31108503
[TBL] [Abstract][Full Text] [Related]
18. Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort.
Sugimoto N; Tanaka E; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Yamaguchi R; Ikari K; Nakajima A; Yamanaka H; Harigai M
Mod Rheumatol; 2023 Jul; 33(4):715-722. PubMed ID: 35920098
[TBL] [Abstract][Full Text] [Related]
19. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.
Fagerli KM; Kearsley-Fleet L; Mercer LK; Watson K; Packham J; Symmons DPM; Hyrich KL
Rheumatology (Oxford); 2019 Jan; 58(1):80-85. PubMed ID: 30137485
[TBL] [Abstract][Full Text] [Related]
20. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.
Raaschou P; Frisell T; Askling J;
Ann Rheum Dis; 2015 Dec; 74(12):2137-43. PubMed ID: 25107559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
